| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 11/24/2004 | EP1411949A4 8/17 heterocyclic compounds and uses thereof as d-alanyl-d-alanine ligase inhibitors |
| 11/24/2004 | EP1318976B1 Substituted aminopropoxyaryl derivatives useful as agonists for lxr |
| 11/24/2004 | EP1313496B1 Use of a composition comprising an extract of pollen for the treatment of edema |
| 11/24/2004 | EP1313495B1 Use of a composition comprising an extract of pollen for the treatment of hormonally-related disorders |
| 11/24/2004 | EP1313493B1 Use of a composition comprising an extract of pollen for the treatment of irritability |
| 11/24/2004 | EP1313492B1 Use of a composition comprising an extract of pollen for the treatment of dysphoria |
| 11/24/2004 | EP1309556B1 Amlodipine fumarate |
| 11/24/2004 | EP1307201B1 Selective pde 2 inhibitors, used as medicaments for improving cognition |
| 11/24/2004 | EP1305306B1 2-adamantylethylamines and their use in the treatment of conditions generally associated with abnormalities in glutamatergic transmission |
| 11/24/2004 | EP1272201B1 Use of compatible solutes as substances having free radical scavenging properties |
| 11/24/2004 | EP1267841B1 Controlled release pharmaceutical composition containing midodrine and/or desglymidodrine |
| 11/24/2004 | EP1263747B1 1,5-benzothiazepines and their use as hypolipidaemics |
| 11/24/2004 | EP1261324B1 Use of tramadol for the preparation of a medicament for the treatment of functional gastrointestinal disorders |
| 11/24/2004 | EP1259498B1 8,8a-dihydro-indeno 1,2-d]thiazole derivatives, substituted in position 8a, a method for their production and their use as medicaments, e.g. anorectic agents |
| 11/24/2004 | EP1221917B1 Drug delivery device |
| 11/24/2004 | EP1214078B1 Formulations for parenteral use of estramustine phosphate and amino acids |
| 11/24/2004 | EP1200406B1 Cyclic amides and imides having selective antagonist activity at alpha-1d adrenergic receptor |
| 11/24/2004 | EP1185536B1 Hemisynthetic method and intermediates thereof |
| 11/24/2004 | EP1183231B1 Cytofectin dimers and methods of use thereof |
| 11/24/2004 | EP1180030B1 Antibacterial compounds |
| 11/24/2004 | EP1175214B1 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect |
| 11/24/2004 | EP1159265B1 C-16 unsaturated fp-selective prostaglandins analogs |
| 11/24/2004 | EP1156800A4 Method for treating exercise induced asthma |
| 11/24/2004 | EP1146883A4 Modulation of immune response by ribavirin |
| 11/24/2004 | EP1143962B1 Parenteral solution of propofol (2,6-diisoprophylphenol) and 2.5-di-0-methyl-1.4;3.6-dianhydro-d-glucitol as a solvent |
| 11/24/2004 | EP1133286B1 Solid lipidic nanospheres suitable to a fast internalization into cells |
| 11/24/2004 | EP1128738B9 A method for supplying bioavailable methionine to a cow |
| 11/24/2004 | EP1109550B1 Novel nitrophenylaziridine compounds and their use as prodrugs |
| 11/24/2004 | EP1107971B1 Porphyrin derivatives, their use in photodynamic therapy and medical devices containing them |
| 11/24/2004 | EP1100465B1 Medicinal aerosol formulations |
| 11/24/2004 | EP1098655B1 Nutritional and therapeutic uses of 3-hydroxyalkanoate oligomers |
| 11/24/2004 | EP1094711B1 Methods for eradication of nanobacteria |
| 11/24/2004 | EP1076055B1 1- (1-substituted-4-piperidinyl)methyl]-4-piperidine derivatives, process for producing the same, medicinal compositions containing the same and intermediates of these compounds |
| 11/24/2004 | EP1033985B1 Stable ascorbic acid preparation for topical use |
| 11/24/2004 | EP1014886B1 Synergistic analgesic combination of opioid analgesic and cyclooxygenase-2 inhibitor |
| 11/24/2004 | EP1011664B1 8a-AZALIDES AS VETERINARY ANTIMICROBIAL AGENTS |
| 11/24/2004 | EP1007677B1 Protease-related protein |
| 11/24/2004 | EP1003496B1 Medicament for treating prostate intraepithelial neoplasia |
| 11/24/2004 | EP0989846B1 Non-irritating cosmetic and pharmaceutical compositions |
| 11/24/2004 | EP0976732B1 1,4-substituted cyclic amine derivatives |
| 11/24/2004 | EP0969838B1 Controlled release compositions for the treatment of hyperlipidemia |
| 11/24/2004 | EP0960111B1 Morphine derivatives with analgesic activity |
| 11/24/2004 | EP0951481B1 Use of substances with immunomodulating activity for the treatment of amyotrophic lateral sclerosis |
| 11/24/2004 | EP0946185B1 PHARMACEUTICAL COMPOSITION COMPRISING A COMPOUND HAVING ANTI-Xa ACTIVITY AND A PLATELET AGGREGATION ANTAGONIST COMPOUND |
| 11/24/2004 | EP0929538B1 O?2 -arylated or o?2 -glycosylated 1-substituted diazen-1-ium-1,2-diolates and o?2 -substituted 1- (2-carboxylato)pyrrolidin-1-yl]diazen-1-ium-1,2-diolates |
| 11/24/2004 | EP0914333B1 Peptide derivatives |
| 11/24/2004 | EP0912157B1 Isolated arachidonic acid-binding heteromer and its use in cosmetics and pharmaceutics |
| 11/24/2004 | EP0889731B1 Injectable therapy for control of muscle spasms and pain related to muscle spasms |
| 11/24/2004 | EP0856157B1 Tumour-specific p450 protein |
| 11/24/2004 | EP0830140B1 A pluripotent vaccine against enveloped viruses |
| 11/24/2004 | EP0783317B1 Mimetics of senescent cell derived inhibitors of dna synthesis |
| 11/24/2004 | EP0752903B1 Solvent extraction process |
| 11/24/2004 | EP0688220B1 Use of dhea and derivatives thereof for the manufacture of a medicament for preventing progressive tissue necrosis, reperfusion injury, bacterial translocation and adult respiratory distress syndrome |
| 11/24/2004 | CN1549829A Chitosan-thio-amidine conjugates and their cosmetic as well as pharmaceutic use |
| 11/24/2004 | CN1549826A Compositions and methods of treating diabetes |
| 11/24/2004 | CN1549822A Methylene-4-azasteroids |
| 11/24/2004 | CN1549817A Pyrrolo pyrimidines, process for their preparation, their use and pharmaceutical compositions containing them |
| 11/24/2004 | CN1549816A N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 11/24/2004 | CN1549814A Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1) |
| 11/24/2004 | CN1549813A Pyrimidineamines as angiogenesis modulators |
| 11/24/2004 | CN1549812A Pyrazole compounds useful as protein kinase inhibitors. |
| 11/24/2004 | CN1549809A Dithiazole compounds, matrix metalloprotease inhibitors and external preparations for the skin |
| 11/24/2004 | CN1549808A New mandelic acid derivatives and their use as thrombin inhibitors |
| 11/24/2004 | CN1549803A 维生素d的类似物 Analogs of vitamin d |
| 11/24/2004 | CN1549734A Aromatase inhibition to enhance assisted reproduction |
| 11/24/2004 | CN1549731A Stilbene derivatives and their use for binding and imaging amyloid plaques |
| 11/24/2004 | CN1549729A 化合物 Compound |
| 11/24/2004 | CN1549720A Oral compositions for the treatment of scalp disorders |
| 11/24/2004 | CN1549719A Use of pregnane-diones or diols as neuropathic analgesic agents |
| 11/24/2004 | CN1549718A Use of compounds for treating conditions resulting from injury to the corneal nerve after LASIK and other ocular surgeries |
| 11/24/2004 | CN1549717A Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidine structure and cathepsin k inhibitory activity, process for producing them and pharmaceutical compositions containing them |
| 11/24/2004 | CN1549716A 3-substituted 6,7-dihydroxytetrahydroisoquinoline derivatives for use as antibacterial agents |
| 11/24/2004 | CN1549715A Piperidin-2,6-dione salts and its use in the treatment of stress-related affective disorders |
| 11/24/2004 | CN1549714A Aminoisoxazole derivatives active as kinase inhibitors |
| 11/24/2004 | CN1549713A Diaryl cycloalkyl derivatives, the use thereof as PPAR activators and pharmaceutical compositions containing thereof |
| 11/24/2004 | CN1549712A Antitumor agents and process for producing the same |
| 11/24/2004 | CN1549711A Use of condensed pyrrole compound in treatment of articular cartilage and bone tissue under cartilage degeneration |
| 11/24/2004 | CN1549710A Compositions comprising pectin and ascorbic acid |
| 11/24/2004 | CN1549709A Application of one antiviral compound in production of preparation for treating respiratory virus infection |
| 11/24/2004 | CN1549708A Anti-influenza agent |
| 11/24/2004 | CN1549707A Beta-adrenergic blockade reversal of catabolism after severe burn |
| 11/24/2004 | CN1549705A Extended release oral dosage form |
| 11/24/2004 | CN1549704A Stabilized oral suspension formulation |
| 11/24/2004 | CN1549703A 药物输送体系 Drug delivery system |
| 11/24/2004 | CN1548452A One kind of membrane protein of SARS coronavirus and its encoding gene and application |
| 11/24/2004 | CN1548445A N-crotonoyl hydroxy protected glucosamine and its prepn and application |
| 11/24/2004 | CN1548444A Synergistic precursor medicine compound for treating Alzheimer disease |
| 11/24/2004 | CN1548443A Phenol containing diphosphonic acid derivative and its prepn and application |
| 11/24/2004 | CN1548436A Novel 2-alkyl substituted imidazole compounds |
| 11/24/2004 | CN1548435A Gatifloxacin hydrobride as quinolone compound and its prepn and application as antibacterial agent |
| 11/24/2004 | CN1548434A Benzothiophene compounds and their prepn and medicine use |
| 11/24/2004 | CN1548432A Stabilizing method and medicine composition of catechin monomer |
| 11/24/2004 | CN1548429A Andrographolide-trimaleate and its salt and their medicine composition |
| 11/24/2004 | CN1548423A Application of bisbenzylisoquinoline-(7-0-11')-single ether bond alkaloid derivative and analog in treating fibrosis related diseases |
| 11/24/2004 | CN1548421A Tilmisartan salt and its prepn |
| 11/24/2004 | CN1548416A Prepn of aluminium zirconium glycinate as antiperspirant |
| 11/24/2004 | CN1548413A Beta-diketoacid as dimer compound and its prepn and use |
| 11/24/2004 | CN1548157A SARS resisting medicine action target and its preventing and treating medicine |
| 11/24/2004 | CN1548145A Medicine composition containing epimedium extract |
| 11/24/2004 | CN1548079A Active part and effective component of Four Drug Decoction |